Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

MedSci Healthcare Holdings Limited (2415.HK)

Compare
1.020
+0.010
+(0.99%)
As of 9:47:43 AM GMT+8. Market Open.
Loading Chart for 2415.HK
  • Previous Close 1.010
  • Open 1.020
  • Bid 1.020 x --
  • Ask 1.070 x --
  • Day's Range 1.020 - 1.020
  • 52 Week Range 0.610 - 3.300
  • Volume 3,000
  • Avg. Volume 718,572
  • Market Cap (intraday) 546.558M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 20.40
  • EPS (TTM) 0.050
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medsci Healthcare Holdings Limited operates as an online professional physician platform service provider in the People's Republic of China and the United States. The company offers precision omni-channel marketing solutions, including precision detailing, medical content creation, and online survey services; physician platform solutions, such as medical knowledge and clinical study assistance services; and real-world study solutions comprising digital real-world evidence-based research. It primarily serves pharmaceutical and medical device companies, physicians, non-profit organizations, and hospitals. The company was founded in 2012 and is headquartered in Shanghai, the People's Republic of China.

medscihealthcare.com

488

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2415.HK

View More

Performance Overview: 2415.HK

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2415.HK
15.91%
HANG SENG INDEX (^HSI)
6.67%

1-Year Return

2415.HK
60.47%
HANG SENG INDEX (^HSI)
28.90%

3-Year Return

2415.HK
88.47%
HANG SENG INDEX (^HSI)
0.56%

5-Year Return

2415.HK
88.47%
HANG SENG INDEX (^HSI)
11.38%

Compare To: 2415.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2415.HK

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    541.20M

  • Enterprise Value

    -737.33M

  • Trailing P/E

    18.99

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.97

  • Price/Book (mrq)

    0.44

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.58%

  • Return on Assets (ttm)

    -0.71%

  • Return on Equity (ttm)

    2.18%

  • Revenue (ttm)

    260.62M

  • Net Income Avi to Common (ttm)

    24.97M

  • Diluted EPS (ttm)

    0.050

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.2B

  • Total Debt/Equity (mrq)

    0.17%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2415.HK

View More

Company Insights: 2415.HK

Research Reports: 2415.HK

View More

People Also Watch